NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its entry into an Amendment to the Stock Purchase Agreement originally entered into as of April 9, 2021 (the “Amendment”) for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd. (collectively the "Hospitals”). The Amendment provided for the
NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced the sale of a $2 Million promissory note (the “Note”) to the Chairman of the Board of the Company, Mr. Fnu Oudom on December 6, 2022. The Note carries an annual interest rate of 6%, which is payable together with the principal amount one year after the date of issuance. Seven business days before the maturity date of th
BIMI intends to use a reverse-stock split to bring the company into compliance with listing requirements of The Nasdaq Capital Market. NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced a 1-for-10 reverse split of its common stock effective December 9, 2022. Beginning on December 12, 2022, the Company’s common stock will trade on Nasdaq on a split adjusted basis. Tradin